HE2RO has been awarded a new 5-year Co-operative Agreement from USAID. This new program, the HIV/AIDS Economics and Research Activity, called EVIDENCE will run from 1st December 2018 to 30th November 2023. EVIDENCE – EValuations to Inform Decisions using EcoNomiCs and Eepidemiology – is a program of applied research and evaluation, including cost and cost effectiveness analysis, cost modelling, and epidemiological analysis, aimed at assisting the Government of South Africa (GoSA) to achieve the goals of its National Strategic Plan on HIV, TB and STIs 2017-2022 (NSP), national and international 90-90-90 targets, and PEPFAR COP 18 objectives.
Stay up to date
Receive newsletters and keep up to date with developments at HE2RO.